These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1. Lebars I; Richard T; Di Primo C; Toulmé JJ Blood Cells Mol Dis; 2007; 38(3):204-9. PubMed ID: 17300966 [TBL] [Abstract][Full Text] [Related]
27. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Elmén J; Thonberg H; Ljungberg K; Frieden M; Westergaard M; Xu Y; Wahren B; Liang Z; Ørum H; Koch T; Wahlestedt C Nucleic Acids Res; 2005; 33(1):439-47. PubMed ID: 15653644 [TBL] [Abstract][Full Text] [Related]
28. Aptamer-siRNA chimeras: Promising tools for targeting HER2 signaling in cancer. Dhanya CR; Mary AS; Madhavan M Chem Biol Drug Des; 2023 May; 101(5):1162-1180. PubMed ID: 36099164 [TBL] [Abstract][Full Text] [Related]
29. Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2. Wullner U; Neef I; Eller A; Kleines M; Tur MK; Barth S Curr Cancer Drug Targets; 2008 Nov; 8(7):554-65. PubMed ID: 18991566 [TBL] [Abstract][Full Text] [Related]
30. Synergistic inhibition of lung cancer cell invasion, tumor growth and angiogenesis using aptamer-siRNA chimeras. Lai WY; Wang WY; Chang YC; Chang CJ; Yang PC; Peck K Biomaterials; 2014 Mar; 35(9):2905-14. PubMed ID: 24397988 [TBL] [Abstract][Full Text] [Related]
31. DNA Polymerase Variants with High Processivity and Accuracy for Encoding and Decoding Locked Nucleic Acid Sequences. Hoshino H; Kasahara Y; Kuwahara M; Obika S J Am Chem Soc; 2020 Dec; 142(51):21530-21537. PubMed ID: 33306372 [TBL] [Abstract][Full Text] [Related]
32. Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system. Wei J; Song R; Sabbagh A; Marisetty A; Shukla N; Fang D; Najem H; Ott M; Long J; Zhai L; Lesniak MS; James CD; Platanias L; Curran M; Heimberger AB Oncoimmunology; 2022; 11(1):2062827. PubMed ID: 35433114 [TBL] [Abstract][Full Text] [Related]
33. Blocking the maturation of OncomiRNAs using pri-miRNA-17∼92 aptamer in retinoblastoma. Subramanian N; Kanwar JR; Kanwar RK; Krishnakumar S Nucleic Acid Ther; 2015 Feb; 25(1):47-52. PubMed ID: 25513843 [TBL] [Abstract][Full Text] [Related]
35. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy. Li X; Zhao Q; Qiu L J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885 [TBL] [Abstract][Full Text] [Related]
36. The therapeutic potential of LNA-modified siRNAs: reduction of off-target effects by chemical modification of the siRNA sequence. Fluiter K; Mook OR; Baas F Methods Mol Biol; 2009; 487():189-203. PubMed ID: 19301648 [TBL] [Abstract][Full Text] [Related]
37. Properties of an LNA-modified ricin RNA aptamer. Förster C; Zydek M; Rothkegel M; Wu Z; Gallin C; Geßner R; Lisdat F; Fürste JP Biochem Biophys Res Commun; 2012 Mar; 419(1):60-5. PubMed ID: 22326915 [TBL] [Abstract][Full Text] [Related]
38. In silico designed RNA aptamer against epithelial cell adhesion molecule for cancer cell imaging. Bavi R; Liu Z; Han Z; Zhang H; Gu Y Biochem Biophys Res Commun; 2019 Feb; 509(4):937-942. PubMed ID: 30648555 [TBL] [Abstract][Full Text] [Related]